Listen "September 2025 Editor's Summary"
Episode Synopsis
The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist.
Modifiable Lifestyle Factors, Genetic Susceptibility, and Incident Radiographic Axial Spondyloarthritis - doi.org/10.3899/jrheum.2025-0042
Prevalence, Risk Factors, and Outcomes of Chronic Kidney Disease in Patients With Systemic Lupus Erythematosus With and Without Lupus Nephritis - doi.org/10.3899/jrheum.2024-1087
Outcomes in Systemic Sclerosis–Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies - doi.org/10.3899/jrheum.2024-1063
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial - doi.org/10.3899/jrheum.2024-0536
Long-Term Effectiveness and Safety of Denosumab for Osteoporosis in Patients With Rheumatic Diseases - doi.org/10.3899/jrheum.2024-1321
Modifiable Lifestyle Factors, Genetic Susceptibility, and Incident Radiographic Axial Spondyloarthritis - doi.org/10.3899/jrheum.2025-0042
Prevalence, Risk Factors, and Outcomes of Chronic Kidney Disease in Patients With Systemic Lupus Erythematosus With and Without Lupus Nephritis - doi.org/10.3899/jrheum.2024-1087
Outcomes in Systemic Sclerosis–Associated Interstitial Lung Disease Based on Serological Profiles With a Focus on Anticentromere and Anti-RNA Polymerase III Antibodies - doi.org/10.3899/jrheum.2024-1063
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial - doi.org/10.3899/jrheum.2024-0536
Long-Term Effectiveness and Safety of Denosumab for Osteoporosis in Patients With Rheumatic Diseases - doi.org/10.3899/jrheum.2024-1321
More episodes of the podcast The JRHEUM Podcast
October 2025 Editor's Summary
01/10/2025
August 2025 Editor's Summary
01/08/2025
July 2025 Editor's Summary
02/07/2025
June 2025 Editor's Summary
02/06/2025
May 2025 Editor's Summary
30/04/2025
April 2025 Editor's Summary
30/03/2025
March 2025 Editor's Summary
26/02/2025
February 2025 Editor's Summary
30/01/2025
January 2025 Editor's Summary
29/12/2024
December 2024 Editor's Picks
02/12/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.